Green Biologics Ltd. (GBL; Abingdon, Oxfordshire, U.K.; www.greenbiologics.com), an industrial biotechnology company has merged with Butylfuel Inc., a U.S.-based renewable chemicals and biofuels company. The new company will operate under the Green Biologics name and will continue to be headquartered in Abingdon, U.K. with a strong operational presence and commercial focus in the U.S. contributed by Butylfuel Inc., which will become Green Biologics, Inc.
The merged GBL will be a globally managed company focused on the production of C4 chemicals and advanced fuels from renewable feedstocks, primarily from waste and byproduct agricultural sources. GBL has an extensive portfolio of proprietary and engineered Clostridia strains used as biocatalysts to process a wide range of starch, sugar and cellulosic feedstocks. In China, GBL has three projects underway on molasses and corn byproduct feedstocks. In India and Brazil, GBL’s focus is molasses, cane and bagasse. In North America, the focus is on both starch-based and cellulosic feedstocks.